Corrigendum to “Suppression of androgen receptor enhances the self-renewal of mesenchymal stem cells through elevated expression of EGFR” [Biochim. Biophys. Acta. 2013 May; 1833 (5): 1222–34] (Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2013) 1833(5) (1222–1234), (S0167488913000128), (10.1016/j.bbamcr.2013.01.007));Suppression of Androgen Receptor Enhances the Self-renewal of Mesenchymal Stem Cells Through Elevated Expression of EGFR

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 5, 2013, Pages 1222-1234

  Huang, Chiung Kuei ^a   Tsai, Meng Yin ^b   Luo, Jie ^a   Kang, Hong Yo ^b   Lee, Soo Ok ^a   Chang, Chawnshang ^a,c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Androgen receptor; Androgen receptor knockout; Epidermal growth factor receptor; Mesenchymal stem cells; Self renewal

Indexed keywords

ANDROGEN RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HYDROXYFLUTAMIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CELL PROLIFERATION; COLONY FORMING UNIT; CONTROLLED STUDY; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

EID: 84875255672     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2020.118730     Document Type: Erratum

References (52)

1. Strauer B.E., Brehm M., Zeus T., Kostering M., Hernandez A., Sorg R.V., Kogler G., Wernet P. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002, 106:1913-1918.
2. Horwitz E.M., Prockop D.J., Fitzpatrick L.A., Koo W.W., Gordon P.L., Neel M., Sussman M., Orchard P., Marx J.C., Pyeritz R.E., Brenner M.K. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. 1999, 5:309-313.
3. Terai S., Ishikawa T., Omori K., Aoyama K., Marumoto Y., Urata Y., Yokoyama Y., Uchida K., Yamasaki T., Fujii Y., Okita K., Sakaida I. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006, 24:2292-2298.
4. Horwitz E.M., Gordon P.L., Koo W.K., Marx J.C., Neel M.D., McNall R.Y., Muul L., Hofmann T. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:8932-8937.
5. Stamm C., Westphal B., Kleine H.D., Petzsch M., Kittner C., Klinge H., Schumichen C., Nienaber C.A., Freund M., Steinhoff G. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003, 361:45-46.
6. Schroder J., Kahlke V., Book M., Stuber F. Gender differences in sepsis: genetically determined?. Shock 2000, 14:307-310. (discussion 310-303).
7. Burt R.K., Loh Y., Pearce W., Beohar N., Barr W.G., Craig R., Wen Y., Rapp J.A., Kessler J. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 2008, 299:925-936.
8. Toma C., Wagner W.R., Bowry S., Schwartz A., Villanueva F. Fate of culture-expanded mesenchymal stem cells in the microvasculature: in vivo observations of cell kinetics. Circ. Res. 2009, 104:398-402.
9. Crisostomo P.R., Wang M., Herring C.M., Morrell E.D., Seshadri P., Meldrum K.K., Meldrum D.R. Sex dimorphisms in activated mesenchymal stem cell function. Shock 2006, 26:571-574.
10. Crisostomo P.R., Wang M., Herring C.M., Markel T.A., Meldrum K.K., Lillemoe K.D., Meldrum D.R. Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: role of the 55kDa TNF receptor (TNFR1). J. Mol. Cell. Cardiol. 2007, 42:142-149.
11. Kolf C.M., Cho E., Tuan R.S. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res. Ther. 2007, 9:204.
12. Hu C., Wu Y., Wan Y., Wang Q., Song J. Introduction of hIGF-1 gene into bone marrow stromal cells and its effects on the cell's biological behaviors. Cell Transplant. 2008, 17:1067-1081.
13. Xie X., Cao F., Sheikh A.Y., Li Z., Connolly A.J., Pei X., Li R.K., Robbins R.C., Wu J.C. Genetic modification of embryonic stem cells with VEGF enhances cell survival and improves cardiac function. Cloning Stem Cells 2007, 9:549-563.
14. Matsuda T., Nakamura T., Nakao K., Arai T., Katsuki M., Heike T., Yokota T. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J. 1999, 18:4261-4269.
15. Niwa H., Burdon T., Chambers I., Smith A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 1998, 12:2048-2060.
16. Chang C.Y., Hsuuw Y.D., Huang F.J., Shyr C.R., Chang S.Y., Huang C.K., Kang H.Y., Huang K.E. Androgenic and antiandrogenic effects and expression of androgen receptor in mouse embryonic stem cells. Fertil. Steril. 2006, 85(Suppl. 1):1195-1203.
17. Carcamo-Orive I., Tejados N., Delgado J., Gaztelumendi A., Otaegui D., Lang V., Trigueros C. ERK2 protein regulates the proliferation of human mesenchymal stem cells without affecting their mobilization and differentiation potential. Exp. Cell Res. 2008, 314:1777-1788.
18. Li J., Wang G., Wang C., Zhao Y., Zhang H., Tan Z., Song Z., Ding M., Deng H. MEK/ERK signaling contributes to the maintenance of human embryonic stem cell self-renewal. Differentiation 2007, 75:299-307.
19. Yeh S., Tsai M.Y., Xu Q., Mu X.M., Lardy H., Huang K.E., Lin H., Yeh S.D., Altuwaijri S., Zhou X., Xing L., Boyce B.F., Hung M.C., Zhang S., Gan L., Chang C. Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:13498-13503.
20. Bonyadi M., Waldman S.D., Liu D., Aubin J.E., Grynpas M.D., Stanford W.L. Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:5840-5845.
21. Mitchell J.B., McIntosh K., Zvonic S., Garrett S., Floyd Z.E., Kloster A., Di Halvorsen Y., Storms R.W., Goh B., Kilroy G., Wu X., Gimble J.M. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 2006, 24:376-385.
22. Yang Z., Chang Y.J., Yu I.C., Yeh S., Wu C.C., Miyamoto H., Merry D.E., Sobue G., Chen L.M., Chang S.S., Chang C. ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor. Nat. Med. 2007, 13:348-353.
23. Miyamoto H., Yang Z., Chen Y.T., Ishiguro H., Uemura H., Kubota Y., Nagashima Y., Chang Y.J., Hu Y.C., Tsai M.Y., Yeh S., Messing E.M., Chang C. Promotion of bladder cancer development and progression by androgen receptor signals. J. Natl. Cancer Inst. 2007, 99:558-568.
24. Ma W.L., Hsu C.L., Wu M.H., Wu C.T., Wu C.C., Lai J.J., Jou Y.S., Chen C.W., Yeh S., Chang C. Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology 2008, 135:947-955. (955 e941-945).
25. Chuang K.H., Altuwaijri S., Li G., Lai J.J., Chu C.Y., Lai K.P., Lin H.Y., Hsu J.W., Keng P., Wu M.C., Chang C. Neutropenia with impaired host defense against microbial infection in mice lacking androgen receptor. J. Exp. Med. 2009, 206:1181-1199.
26. Miyahara Y., Nagaya N., Kataoka M., Yanagawa B., Tanaka K., Hao H., Ishino K., Ishida H., Shimizu T., Kangawa K., Sano S., Okano T., Kitamura S., Mori H. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat. Med. 2006, 12:459-465.
27. Nishino J., Kim I., Chada K., Morrison S.J. Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf expression. Cell 2008, 135:227-239.
28. Oguro H., Iwama A., Morita Y., Kamijo T., van Lohuizen M., Nakauchi H. Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient mice. J. Exp. Med. 2006, 203:2247-2253.
29. Bendall S.C., Stewart M.H., Menendez P., George D., Vijayaragavan K., Werbowetski-Ogilvie T., Ramos-Mejia V., Rouleau A., Yang J., Bosse M., Lajoie G., Bhatia M. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 2007, 448:1015-1021.
30. Bonaccorsi L., Muratori M., Carloni V., Marchiani S., Formigli L., Forti G., Baldi E. The androgen receptor associates with the epidermal growth factor receptor in androgen-sensitive prostate cancer cells. Steroids 2004, 69:549-552.
31. Bonaccorsi L., Carloni V., Muratori M., Formigli L., Zecchi S., Forti G., Baldi E. EGF receptor (EGFR) signaling promoting invasion is disrupted in androgen-sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR). Int. J. Cancer 2004, 112:78-86.
32. Yu S., Yeh C.R., Niu Y., Chang H.C., Tsai Y.C., Moses H.L., Shyr C.R., Chang C., Yeh S. Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblasts. Prostate 2012, 72:437-449.
33. Lai K.P., Yamashita S., Vitkus S., Shyr C.R., Yeh S., Chang C. Suppressed prostate epithelial development with impaired branching morphogenesis in mice lacking stromal fibromuscular androgen receptor. Mol. Endocrinol. 2012, 26:52-66.
34. Liu P.Y., Death A.K., Handelsman D.J. Androgens and cardiovascular disease. Endocr. Rev. 2003, 24:313-340.
35. Kaushik M., Sontineni S.P., Hunter C. Cardiovascular disease and androgens: a review. Int. J. Cardiol. 2010, 142:8-14.
36. Yeap B.B. Androgens and cardiovascular disease. Curr. Opin. Endocrinol. Diabetes Obes. 2010, 17:269-276.
37. Eugene D., Djemli A., Van Vliet G. Sexual dimorphism of thyroid function in newborns with congenital hypothyroidism. J. Clin. Endocrinol. Metab. 2005, 90:2696-2700.
38. Han H.J., Heo J.S., Lee Y.J. Estradiol-17beta stimulates proliferation of mouse embryonic stem cells: involvement of MAPKs and CDKs as well as protooncogenes. Am. J. Physiol. Cell Physiol. 2006, 290:C1067-1075.
39. Ayaloglu-Butun F., Terzioglu-Kara E., Tokcaer-Keskin Z., Akcali K.C. The effect of estrogen on bone marrow-derived rat mesenchymal stem cell maintenance: inhibiting apoptosis through the expression of Bcl-xL and Bcl-2. Stem Cell Rev. 2012, 8:393-401.
40. Erwin G.S., Crisostomo P.R., Wang Y., Wang M., Markel T.A., Guzman M., Sando I.C., Sharma R., Meldrum D.R. Estradiol-treated mesenchymal stem cells improve myocardial recovery after ischemia. J. Surg. Res. 2009, 152:319-324.
41. Brannvall K., Korhonen L., Lindholm D. Estrogen-receptor-dependent regulation of neural stem cell proliferation and differentiation. Mol. Cell. Neurosci. 2002, 21:512-520.
42. Murashov A.K., Pak E.S., Hendricks W.A., Tatko L.M. 17beta-Estradiol enhances neuronal differentiation of mouse embryonic stem cells. FEBS Lett. 2004, 569:165-168.
43. Leskela H.V., Olkku A., Lehtonen S., Mahonen A., Koivunen J., Turpeinen M., Uusitalo J., Pelkonen O., Kangas L., Selander K., Lehenkari P. Estrogen receptor alpha genotype confers interindividual variability of response to estrogen and testosterone in mesenchymal-stem-cell-derived osteoblasts. Bone 2006, 39:1026-1034.
44. Tsai M.Y., Shyr C.R., Kang H.Y., Chang Y.C., Weng P.L., Wang S.Y., Huang K.E., Chang C. The reduced trabecular bone mass of adult ARKO male mice results from the decreased osteogenic differentiation of bone marrow stroma cells. Biochem. Biophys. Res. Commun. 2011, 411:477-482.
45. Goldman-Johnson D.R., de Kretser D.M., Morrison J.R. Evidence that androgens regulate early developmental events, prior to sexual differentiation. Endocrinology 2008, 149:5-14.
46. Peister A., Mellad J.A., Larson B.L., Hall B.M., Gibson L.F., Prockop D.J. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004, 103:1662-1668.
47. Ning H., Lin G., Lue T.F., Lin C.S. Neuron-like differentiation of adipose tissue-derived stromal cells and vascular smooth muscle cells. Differentiation 2006, 74:510-518.
48. Niu Y., Altuwaijri S., Yeh S., Lai K.P., Yu S., Chuang K.H., Huang S.P., Lardy H., Chang C. Targeting the stromal androgen receptor in primary prostate tumors at earlier stages. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:12188-12193.
49. Lai J.J., Lai K.P., Chuang K.H., Chang P., Yu I.C., Lin W.J., Chang C. Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expression. J. Clin. Invest. 2009, 119:3739-3751.
50. Lin H.Y., Xu Q., Yeh S., Wang R.S., Sparks J.D., Chang C. Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor. Diabetes 2005, 54:1717-1725.
51. Kang H.Y., Shyr C.R., Huang C.K., Tsai M.Y., Orimo H., Lin P.C., Chang C., Huang K.E. Altered TNSALP expression and phosphate regulation contribute to reduced mineralization in mice lacking androgen receptor. Mol. Cell. Biol. 2008, 28:7354-7367.
52. Yeh S., Hu Y.C., Wang P.H., Xie C., Xu Q., Tsai M.Y., Dong Z., Wang R.S., Lee T.H., Chang C. Abnormal mammary gland development and growth retardation in female mice and MCF7 breast cancer cells lacking androgen receptor. J. Exp. Med. 2003, 198:1899-1908.